Kendle completes buy of Mexican CRO

US contract research organization Kendle International has completed its acquisition of Mexican CRO Estadisticos y Clinicos Asociados SA, expanding the company's capability to conduct clinical trials in Latin America. Kendle announced its agreement to acquire ECA August 15.

Under the terms of the acquisition, Kendle has assumed substantially all assets and liabilities of ECA's business for an undisclosed cash amount. Specific terms of the deal were not disclosed. The acquired operations will be conducted under the name Kendle International SA de CV and will be known as Kendle Mexico. The acquisition builds on Kendle's long-standing relationship with ECA, which the US firm had used exclusively in recent years for drug development programs conducted in Latin America.